The FDA's removal of draft guidance on clinical trial diversity raises concerns about its commitment to diversity and compliance with statutory obligations. The draft guidance aimed to improve the ...
Feb 5 (Reuters) - The U.S. Food and Drug Administration's (FDA) website showed that three higher doses of Eli Lilly's (LLY.N), opens new tab diabetes drug, Mounjaro, would be available only in limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback